Serum vitamin D concentrations in young Turkish women with primary dysmenorrhea: A randomized controlled study

What Was Tested

The paper reports a study of Parathyroid Hormone (PTH 1-84), published as a randomized controlled trial.

This study aims to investigate the possible role of vitamin D deficiency in primary dysmenorrhea by assessing serum 25-hydroxyvitamin D3 levels in a cohort which includes young Turkish women with primary dysmenorrhea and healthy controls.

Who Took Part

The abstract describes 683 women taking part.

The age groups tagged for this paper are teenagers, young adults and adults, women only.

A total of 683 women who were aged between 18 and 25 years and who were consecutively admitted to the study center were eligible.

After the exclusion of 55 women, 184 women with primary dysmenorrhea were randomly assigned into the dysmenorrhea group and 184 women without dysmenorrhea were randomly allocated into the control group.

How the Study Was Run

The design is described as randomized.

Because people in this Parathyroid Hormone (PTH 1-84) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

What Was Measured

The subject headings attached to it are Dysmenorrhea, Parathyroid Hormone, Turkey, Vitamin D and Vitamin D Deficiency.

The authors tagged it with the keywords Dairy product and Visual analogue scale.

What This Means in Plain Language

The paper is a randomized study of Parathyroid Hormone (PTH 1-84) in 683 women.

With several hundred people or more, it is a fairly large study for this kind of research.

Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2018 (Taiwanese journal of obstetrics & gynecology), a journal based in China (Republic : 1949- ).

More context: the Parathyroid Hormone (PTH 1-84) compound page, all human trials.